| 1 | Study | 2.5% | |
| 2 | Cancer | 2.5% | |
| 3 | ASCO | 2.5% | |
| 4 | Patients | 1.67% | |
| 5 | Results | 1.67% | |
| 6 | Prostate | 1.67% | |
| 7 | Phase | 1.67% | |
| 8 | Urothelial | 0.83% | |
| 9 | Lurking | 0.83% | |
| 10 | Clinical | 0.83% | |
| 11 | Clinically | 0.83% | |
| 12 | Neoadjuvant | 0.83% | |
| 13 | Predicting | 0.83% | |
| 14 | Rapid | 0.83% | |
| 15 | Reviewed | 0.83% | |
| 16 | Validation | 0.83% | |
| 17 | Ear | 0.83% | |
| 18 | Meningoencephalitis | 0.83% | |
| 19 | Sugar | 0.83% | |
| 20 | Natural | 0.83% | |
| 21 | Ideas | 0.83% | |
| 22 | Advanced | 0.83% | |
| 23 | New | 0.83% | |
| 24 | Molecular | 0.83% | |
| 25 | Africans | 0.83% | |
| 26 | Effusion-Synovitis | 0.83% | |
| 27 | Outcomes | 0.83% | |
| 28 | Multimodal | 0.83% | |
| 29 | External | 0.83% | |
| 30 | Osteoarthritis | 0.83% | |
| 31 | Czechia | 0.83% | |
| 32 | Awesome | 0.83% | |
| 33 | Bryan | 0.83% | |
| 34 | Have | 0.83% | |
| 35 | Stress | 0.83% | |
| 36 | Cisplatin-Ineligible | 0.83% | |
| 37 | (BT8009) | 0.83% | |
| 38 | Diminished | 0.83% | |
| 39 | Relapsing | 0.83% | |
| 40 | Nectin-4?targeting | 0.83% | |
| 41 | Health | 0.83% | |
| 42 | Prostatectomy | 0.83% | |
| 43 | Intelligence | 0.83% | |
| 44 | Leprosy | 0.83% | |
| 45 | Pevedotin | 0.83% | |
| 46 | Nose | 0.83% | |
| 47 | Duravelo-1 | 0.83% | |
| 48 | Metastatic | 0.83% | |
| 49 | Home | 0.83% | |
| 50 | Balance | 0.83% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||